Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
Dronedarone is an amiodarone analog but differs structurally from amiodarone in that the iodine moiety was removed and a methane-sulfonyl group was added. These modifications reduced thyroid and other end-organ adverse effects and makes dronedarone less lipophilic, shortening its half-life. Dronedar...
Main Authors: | Gerald V. Naccarelli, Deborah L. Wolbrette, Vadim Levin, Soraya Samii, Javier E. Banchs, Erica Penny-Peterson, Mario D. Gonzalez |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-01-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.4137/CMC.S6677 |
Similar Items
-
Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
by: Gerald V. Naccarelli, et al.
Published: (2011-10-01) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
by: Deborah Wolbrette, et al.
Published: (2010-06-01) -
Dronedarone for the treatment of atrial fibrillation and atrial flutter
by: E Maund, et al.
Published: (2010-10-01) -
Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
by: Christine Benn Christiansen, et al.
Published: (2010-03-01) -
Dronedarone in the management of atrial fibrillation
by: TS Mohamed Saleem, et al.
Published: (2010-03-01)